COMPARATIVE SAFETY AND IMMUNOGENICITY OF TWO YELLOW FEVER 17 D VACCINES ( ARILVAX AND YF-VAX ) IN A PHASE III MULTICENTER , DOUBLE-BLIND CLINICAL TRIAL